Cas:269410-23-3 3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester manufacturer & supplier

Chemical Name:3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester

CAS.NO:269410-23-3

Synonyms:2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol;3-Hydroxy-4-methoxyphenylboronic acid pinacol ester;3-Hydroxy-4-methoxyphenylboronic acid,pinacol ester

Molecular Formula:C₁₃H₁₉BO₄

Molecular Weight:250.09900

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:369.1ºC at 760mmHg

Density:1.11g/cm3

Index of Refraction:1.512

PSA:47.92000

Exact Mass:250.13800

LogP:1.70000

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Hydroxy-4-methoxyphenylboronic acid,pinacol ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Hydroxy-4-methoxyphenylboronic acid pinacol ester Use and application,2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol technical grade,usp/ep/jp grade.

Related News: Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs. 3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester manufacturer AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester supplier The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. 3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester vendor Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. 3-Hydroxy-4-methoxyphenylboronic acid, pinacol ester factory AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment.